Mirum Pharmaceuticals, Inc.: cash_and_equivalents
| Value | {"amount": 51963000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2018-12-31) |
| Status | current |
| Entity | Mirum Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:53:34.758910+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/82cc6d65-098f-4169-bc11-26f90dfb53b2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-19-033345Retrieved: 2026-08-19T17:53:34.758910+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001759425/cash-and-equivalents/2018-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/82cc6d65-098f-4169-bc11-26f90dfb53b2
History
- no predecessors — first report